Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To test the safety and efficacy of a new generation botulinum toxin preparation A2NTX for
treating stroke patients with lower limb spasticity.
- we study the degree of spasticity in the ankle and knee joints, and walking speed in 30
patients with stroke before and after injecting 300 units of BOTOX or A2NTX in a blinded
manner as for the patient, the physician, and the examiner.
- we also assess the safety of A2NTX and compare it to that of BOTOX.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Tokushima
Collaborator:
Ministry of Health, Labour and Welfare, Japan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA